8BYJ image
Entry Detail
PDB ID:
8BYJ
Title:
The structures of Ace2 in complex with bicyclic peptide inhibitor
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2022-12-13
Release Date:
2023-09-20
Method Details:
Experimental Method:
Resolution:
2.07 Å
R-Value Free:
0.30
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Processed angiotensin-converting enzyme 2
Chain IDs:A, B
Chain Length:609
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-ARG-ILE-HIS-CYS-ALA
Chain IDs:C, D
Chain Length:18
Number of Molecules:2
Biological Source:synthetic construct
Primary Citation
Structure-Guided Chemical Optimization of Bicyclic Peptide ( Bicycle ) Inhibitors of Angiotensin-Converting Enzyme 2.
J.Med.Chem. 66 9881 9893 (2023)
PMID: 37433017 DOI: 10.1021/acs.jmedchem.3c00710

Abstact

Angiotensin-converting enzyme 2 (ACE2) is a metalloprotease that cleaves angiotensin II, a peptide substrate involved in the regulation of hypertension. Here, we identified a series of constrained bicyclic peptides, Bicycle, inhibitors of human ACE2 by panning highly diverse bacteriophage display libraries. These were used to generate X-ray crystal structures which were used to inform the design of additional Bicycles with increased affinity and inhibition of ACE2 enzymatic activity. This novel structural class of ACE2 inhibitors is among the most potent ACE2 inhibitors yet described in vitro, representing a valuable tool to further probe ACE2 function and for potential therapeutic utility.

Legend

Protein

Chemical

Disease

Primary Citation of related structures